WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

Kenneth Kwok  1     Severine Vermeire  2     Irene Modesto  3     David T. Rubin  4     Silvio Danese  5     Siew C. Ng  6     Nana Koram     Thomas V Jones    
1 Pfizer Inc,New York,United States
2 University Hospitals Leuven,Leuven,Belgium
3 Pfizer Inc,New Yor,United States
4 University of Chicago Medicine Inflammatory Bowel Disease Center,Chicago,United States
5 Humanitas University,Milan,Italy
6 LKS Institute of Health Science, Chinese University of Hong Kong, Institute of Digestive Disease,Hong

Session
Safety and outcomes of interventions in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing